Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
Main Authors: | Edwards, C, Edwards, JR, Lwin, S, Mundy, G |
---|---|
Format: | Conference item |
Published: |
2007
|
Similar Items
-
Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
by: Edwards, C, et al.
Published: (2008) -
EphB4 Expression in Osteoblasts is Regulated by Myeloma Cells and the Wnt Signaling Pathway.
by: Bates, A, et al.
Published: (2008) -
Wnt signaling: bone's defense against myeloma.
by: Edwards, C
Published: (2008) -
Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
by: Fowler, J, et al.
Published: (2010) -
Lithium inhibits the development of myeloma bone disease in vivo.
by: Edwards, C, et al.
Published: (2006)